View Author
peptide protein fusion hr 2 peptides sars-cov infection hr 1–hr fusion peptide spike coronaviru region membrane virus sequence pnas web site inhibition class domain residue hr 2 peptide coronavirus spike proteins sars-cov infection formation hr 1–hr complexes complex sars-cov spike protein hr 1 region ec 50 values fusion proteins vero 118 cells transmembrane temperature analysis concentration hr peptides coronaviruse vero cells 37° c membrane fusion heptad value six-helix hr 1 peptides hr 1 peptide stability c-terminal structure bundle spectrometry n terminus transmembrane domain six-helix bundle mhv infection mixture virol tricine antiparallel strain sample n-terminal 2-1 bosch cleavage alignment hr 2 helices room temperature ec 50 value sars-cov hr 1 subunit nontagged hr peptides nano-esi-tof mass spectrometry equimolar information hr 2 region proteinase hr 2-derived peptides hr 2 domain process hr 2-1 peptide mhv spike protein
1 Most Recent Publications
|
Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.
(Article)
Bosch, B.J. Martina, B.E.E. Zee, R. van der Lepault, J. Haijema, B.J. Versluis, C. Heck, A.J.R. Groot, R. de Osterhaus, A.D.M.E. Rottier, P.J.M. |
2004-06-01
|